JP2009510095A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009510095A5 JP2009510095A5 JP2008533628A JP2008533628A JP2009510095A5 JP 2009510095 A5 JP2009510095 A5 JP 2009510095A5 JP 2008533628 A JP2008533628 A JP 2008533628A JP 2008533628 A JP2008533628 A JP 2008533628A JP 2009510095 A5 JP2009510095 A5 JP 2009510095A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- substituted
- compound according
- alkyl
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 39
- 208000002193 Pain Diseases 0.000 claims 16
- -1 alkyl sulfone Chemical group 0.000 claims 15
- 229910052799 carbon Inorganic materials 0.000 claims 14
- 230000002265 prevention Effects 0.000 claims 14
- 208000024891 symptom Diseases 0.000 claims 12
- 125000003118 aryl group Chemical group 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 11
- 125000001072 heteroaryl group Chemical group 0.000 claims 10
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical group FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims 10
- 229910052739 hydrogen Inorganic materials 0.000 claims 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000000304 alkynyl group Chemical group 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- 229910052731 fluorine Inorganic materials 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 230000001457 vasomotor Effects 0.000 claims 5
- 208000001640 Fibromyalgia Diseases 0.000 claims 4
- 125000004423 acyloxy group Chemical group 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 230000001668 ameliorated effect Effects 0.000 claims 4
- 150000001721 carbon Chemical group 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 4
- 230000000407 monoamine reuptake Effects 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 3
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 3
- 201000001880 Sexual dysfunction Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 230000002496 gastric effect Effects 0.000 claims 3
- 208000014674 injury Diseases 0.000 claims 3
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 3
- 231100000872 sexual dysfunction Toxicity 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 2
- 208000013586 Complex regional pain syndrome type 1 Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000001947 Reflex Sympathetic Dystrophy Diseases 0.000 claims 2
- 229910005965 SO 2 Inorganic materials 0.000 claims 2
- 206010066218 Stress Urinary Incontinence Diseases 0.000 claims 2
- 208000000921 Urge Urinary Incontinence Diseases 0.000 claims 2
- 208000027418 Wounds and injury Diseases 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 125000005360 alkyl sulfoxide group Chemical group 0.000 claims 2
- 125000004422 alkyl sulphonamide group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000002837 carbocyclic group Chemical group 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 claims 2
- 125000006622 cycloheptylmethyl group Chemical group 0.000 claims 2
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 2
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 claims 2
- 230000006378 damage Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 208000024714 major depressive disease Diseases 0.000 claims 2
- 230000009245 menopause Effects 0.000 claims 2
- 208000004296 neuralgia Diseases 0.000 claims 2
- 208000021722 neuropathic pain Diseases 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 2
- 230000002093 peripheral effect Effects 0.000 claims 2
- 125000006413 ring segment Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 208000009935 visceral pain Diseases 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 206010005052 Bladder irritation Diseases 0.000 claims 1
- 206010006002 Bone pain Diseases 0.000 claims 1
- 206010058019 Cancer Pain Diseases 0.000 claims 1
- 206010064012 Central pain syndrome Diseases 0.000 claims 1
- 206010050217 Cervical radiculopathy Diseases 0.000 claims 1
- 208000018380 Chemical injury Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- 208000007882 Gastritis Diseases 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 208000021965 Glossopharyngeal Nerve disease Diseases 0.000 claims 1
- 208000033830 Hot Flashes Diseases 0.000 claims 1
- 206010060800 Hot flush Diseases 0.000 claims 1
- 206010065390 Inflammatory pain Diseases 0.000 claims 1
- 208000008930 Low Back Pain Diseases 0.000 claims 1
- 206010050219 Lumbar radiculopathy Diseases 0.000 claims 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 208000010886 Peripheral nerve injury Diseases 0.000 claims 1
- 206010065016 Post-traumatic pain Diseases 0.000 claims 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 claims 1
- 206010037779 Radiculopathy Diseases 0.000 claims 1
- 206010041250 Social phobia Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000025609 Urogenital disease Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 238000002266 amputation Methods 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 230000037007 arousal Effects 0.000 claims 1
- 125000005362 aryl sulfone group Chemical group 0.000 claims 1
- 125000004421 aryl sulphonamide group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 210000000013 bile duct Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 230000006835 compression Effects 0.000 claims 1
- 238000007906 compression Methods 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 201000005442 glossopharyngeal neuralgia Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000008595 infiltration Effects 0.000 claims 1
- 238000001764 infiltration Methods 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 230000001394 metastastic effect Effects 0.000 claims 1
- 206010061289 metastatic neoplasm Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 208000030212 nutrition disease Diseases 0.000 claims 1
- 208000019180 nutritional disease Diseases 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical class CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims 1
- PYNUOAIJIQGACY-UHFFFAOYSA-N propylazanium;chloride Chemical compound Cl.CCCN PYNUOAIJIQGACY-UHFFFAOYSA-N 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 230000035946 sexual desire Effects 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 230000007863 steatosis Effects 0.000 claims 1
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 1
- 208000012720 thalamic disease Diseases 0.000 claims 1
- 230000000542 thalamic effect Effects 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 206010044652 trigeminal neuralgia Diseases 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72169305P | 2005-09-29 | 2005-09-29 | |
| PCT/US2006/037962 WO2007041258A1 (en) | 2005-09-29 | 2006-09-27 | Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009510095A JP2009510095A (ja) | 2009-03-12 |
| JP2009510095A5 true JP2009510095A5 (https=) | 2009-09-24 |
Family
ID=37684875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008533628A Withdrawn JP2009510095A (ja) | 2005-09-29 | 2006-09-27 | モノアミン再取り込みにより改善する症状の処置において使用するためのベンゾチアジアゾリフェニルアルキルアミン誘導体 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7601744B2 (https=) |
| EP (1) | EP1934193A1 (https=) |
| JP (1) | JP2009510095A (https=) |
| KR (1) | KR20080050453A (https=) |
| CN (1) | CN101277941A (https=) |
| AR (1) | AR055660A1 (https=) |
| AU (1) | AU2006297208A1 (https=) |
| BR (1) | BRPI0616462A2 (https=) |
| CA (1) | CA2624096A1 (https=) |
| CR (1) | CR9829A (https=) |
| EC (1) | ECSP088300A (https=) |
| GT (1) | GT200600441A (https=) |
| IL (1) | IL190273A0 (https=) |
| NO (1) | NO20081235L (https=) |
| PE (1) | PE20070544A1 (https=) |
| RU (1) | RU2008110082A (https=) |
| TW (1) | TW200804325A (https=) |
| WO (1) | WO2007041258A1 (https=) |
| ZA (1) | ZA200802774B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2007003590A1 (es) | 2006-12-12 | 2008-02-29 | Wyeth Corp | Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt |
| US20090156826A1 (en) * | 2007-12-12 | 2009-06-18 | Wyeth | Methods for the preparation of hydroxy-substituted aryl sulfamide compounds |
| KR20100137473A (ko) * | 2008-02-19 | 2010-12-30 | 아돌로 코포레이션 | 동통 치료를 위한 벨록세핀, 이의 거울상이성질체, 및 이의 유사체 |
| US20090233959A1 (en) | 2008-02-19 | 2009-09-17 | Adolor Corporation | Beloxepin and analogs for the treatment of pain |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3306399A (en) | 1998-03-02 | 1999-09-20 | Eli Lilly And Company | Fluoxetine hydrochloride for decreasing hot flashes |
| WO2004043903A1 (en) * | 2002-11-05 | 2004-05-27 | Eli Lilly And Company | 3-aryloxy/ thio-2, 3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
| US7491723B2 (en) * | 2003-10-14 | 2009-02-17 | Wyeth | Alkanol and cycloalkanol-amine derivatives and methods of their use |
-
2006
- 2006-09-27 TW TW095135772A patent/TW200804325A/zh unknown
- 2006-09-27 BR BRPI0616462-5A patent/BRPI0616462A2/pt not_active IP Right Cessation
- 2006-09-27 US US11/528,792 patent/US7601744B2/en not_active Expired - Fee Related
- 2006-09-27 RU RU2008110082/04A patent/RU2008110082A/ru not_active Application Discontinuation
- 2006-09-27 EP EP06815744A patent/EP1934193A1/en not_active Withdrawn
- 2006-09-27 GT GT200600441A patent/GT200600441A/es unknown
- 2006-09-27 PE PE2006001171A patent/PE20070544A1/es not_active Application Discontinuation
- 2006-09-27 AR ARP060104235A patent/AR055660A1/es unknown
- 2006-09-27 CA CA002624096A patent/CA2624096A1/en not_active Abandoned
- 2006-09-27 CN CNA2006800360246A patent/CN101277941A/zh active Pending
- 2006-09-27 JP JP2008533628A patent/JP2009510095A/ja not_active Withdrawn
- 2006-09-27 KR KR1020087007611A patent/KR20080050453A/ko not_active Withdrawn
- 2006-09-27 WO PCT/US2006/037962 patent/WO2007041258A1/en not_active Ceased
- 2006-09-27 AU AU2006297208A patent/AU2006297208A1/en not_active Abandoned
-
2008
- 2008-03-10 NO NO20081235A patent/NO20081235L/no unknown
- 2008-03-18 IL IL190273A patent/IL190273A0/en unknown
- 2008-03-20 EC EC2008008300A patent/ECSP088300A/es unknown
- 2008-03-26 CR CR9829A patent/CR9829A/es not_active Application Discontinuation
- 2008-03-28 ZA ZA200802774A patent/ZA200802774B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007516941A5 (https=) | ||
| JP2007508361A5 (https=) | ||
| JP2002523508A5 (https=) | ||
| JP2002523491A5 (https=) | ||
| JP2005527579A5 (https=) | ||
| JP2019511489A5 (https=) | ||
| JP2007508360A5 (https=) | ||
| MY200172A (en) | Methods and compositions for treating sleep apnea | |
| JP2015531764A5 (https=) | ||
| JP2002536445A5 (https=) | ||
| JP2002535408A5 (https=) | ||
| GEP20094851B (en) | Selective androgen receptor modulators and methods of use thereof | |
| HRP20220642T1 (hr) | Postupci za liječenje depresije uporabom antagonista receptora oreksina 2 | |
| JP2006527776A5 (https=) | ||
| JP2012526107A5 (https=) | ||
| EA201890402A1 (ru) | 5-htрецепторные агонисты и композиции и способы применения | |
| JP2016522254A5 (https=) | ||
| JP2018522025A5 (https=) | ||
| JP2006525297A5 (https=) | ||
| JP2005530779A5 (https=) | ||
| JP2012531402A5 (https=) | ||
| EA201990527A1 (ru) | Агонисты рецептора 5-htи композиции, а также способ их применения | |
| JP2011525185A5 (https=) | ||
| JP2009510095A5 (https=) | ||
| JP2007531750A5 (https=) |